Valuation Supernus, Inc.

Stocks

Delayed Nasdaq 01:53:30 07/11/26 am AEDT			5-day change	1st Jan Change
26.50 ^USD	-0.90%		-24.95%	-26.02%

04/11	Supernus, Inc.(NasdaqGS:SUPN) added to NASDAQ Composite Index	CI
03/11	Indivior Pharmaceuticals, Inc. completed the acquisition of Supernus Pharmaceuticals, Inc. from group of shareholders in a merger of equals transaction.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	5,555	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	23.99%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	5,542	4,985	4,364
Change	-	55.81%	-17.52%	-21.95%	193.72%	20.38%	-10.06%	-12.45%
P/E	12.8x	-57.2x	1,527x	-34.5x	21.9x	7.19x	6.51x	10.7x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0x	0.6x	-0.3x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	2.45x	2.28x	2.07x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	2.45x	2.05x	1.62x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	5.94x	4.41x	3.29x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	6.01x	4.45x	4.48x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	7.21x	8.83x	3.9x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	13.9%	11.3%	25.7%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.72	4.105	2.51
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	2,264	2,432	2,686
EBITDA ¹	202	225	288	338	428	932.3	1,130	1,327
EBIT ¹	187	212	269	312	415	922.3	1,120	974
Net income ¹	205	-53	2	-48	210	474.3	530	525.2
Net Debt ¹	-860	-534	-77	14	124	-12.5	-570	-1,191
Reference price ²	17.25	21.75	15.27	12.43	35.88	26.74	26.74	26.74
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	207,724	-	-
Announcement Date	16/2/22	16/2/23	22/2/24	20/2/25	26/2/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SUPERNUS, INC.	7.19x	4.16x	7.61x	-	5.55B
ELI LILLY AND COMPANY	39.94x	13.51x	30.01x	0.5%	1,216B
JOHNSON & JOHNSON	39.86x	6.69x	18.83x	1.96%	656B
ABBVIE INC.	37.08x	8.43x	17.39x	2.4%	509B
ROCHE HOLDING AG	21.12x	5.13x	12.77x	2.56%	384B
MERCK & CO., INC.	97.32x	5.95x	25.36x	2.32%	362B
NOVARTIS AG	23.5x	6.02x	14.53x	2.65%	311B
ASTRAZENECA PLC	24.85x	4.96x	13.98x	1.76%	293B
AMGEN INC.	28.41x	7.33x	12.69x	2.19%	249B
GILEAD SCIENCES, INC.	-40.11x	7.32x	45.99x	1.97%	208B
Average	27.92x	6.95x	19.91x	2.03%	419.33B
Weighted average by Cap.	35.84x	8.57x	22.21x	1.73%